Scarlet Therapeutics Ltd
We believe the future of medicine is in our blood.
13 employees · est. 2022 · Bristol, United Kingdom
T-Cypher Bio
Unlocking an expansive target space to build a pipeline of novel, TCR-based therapeutics.
35 employees · est. 2021 · Oxford, United Kingdom
T-Cypher Bio is the older company (2022 vs 2021).
Side-by-Side Comparison
| Metric | Scarlet Therapeutics Ltd | T-Cypher Bio |
|---|---|---|
| Founded | ||
| Founded | 2022 | 2021 older |
| Headquarters | ||
| Headquarters | Bristol, United Kingdom | Oxford, United Kingdom |
| Employees | ||
| Employees | 13 | 35 |
| Industry | ||
| Industry | Biotechnology, Health and Wellness | Biotechnology |
| Funding Stage | ||
| Funding Stage | Seed | Seed |
| Total Funding | ||
| Total Funding | Not tracked yet | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 1 | 1 |
| Services | ||
| Services | Not tracked yet | Development of novel TCR-based therapeutics for immune-mediated diseases and oncology, immune system data analysis, computational modeling for T cell immunology. |
| Target Customers | ||
| Target Customers | Not tracked yet | Biotechnology and pharmaceutical companies, oncology clinics, healthcare institutions, research organizations, patients with immune-mediated diseases and solid tumors. |
| Taxonomy | ||
| Taxonomy | Medical Research, Red Blood Cell Therapy, Metabolic Diseases, Rare Diseases, Cancer Treatment, Autoimmune Disease, Therapeutic Protein, University Of Bristol, Clinical Study, License Technology, Drug Development, Healthcare Innovation, Life Sciences, Cell Therapy | TCR-based Therapeutics, Immune-mediated Disease, Oncology, Solid Tumor Treatment, Autoimmune Diseases, Infectious Diseases, Therapeutic Targets, T Cell Immunology, High-throughput Profiling, Computational Modeling, Biopharmaceutical, Platform Technology, T Cell Specificity, Drug Development |
| Website | ||
| Website | scarlet-tx.com | tcypherbio.com |
About Scarlet Therapeutics Ltd
Scarlet Therapeutics Ltd is a pioneering biotechnology startup headquartered in United Kingdom, founded in 2022. Embracing the slogan "We believe the future of medicine is in our blood," the company is focused on developing a unique platform that generates novel red blood cell-based therapeutics to...
About T-Cypher Bio
T-Cypher Bio is a biotechnology startup founded in 2021 and headquartered in the United Kingdom. The company's mission, encapsulated in the slogan "Unlocking an expansive target space to build a pipeline of novel, TCR-based therapeutics," reflects its core focus on generating novel TCR-based therape...
We will tell you when either one moves
BounceWatch watches Scarlet Therapeutics Ltd and T-Cypher Bio for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Scarlet Therapeutics L... and T-Cypher Bio — by email.
Frequently Asked Questions
Compare Scarlet Therapeutics Ltd with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Scarlet Therapeutics Ltd on 11 Sep 2024, and T-Cypher Bio on 13 Apr 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
